Nanomedicinal Approach of Getting Across the Brood-Brain Barrier with Nanomedicinal Nanoparticles

Author(s): D. Psimadas, T. Tsotakos, E. Fragogeorgi, G. Loudos

Journal Name: Current Medicinal Chemistry

Volume 22 , Issue 37 , 2015

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer


Passage into the brain has always been a major challenge for medicine in order to treat malfunctions of the central nervous system (CNS). The blood-brain-barrier (BBB) is a physical obstacle that controls the entrance of substances -including pharmaceuticals- into the brain. The application of nanotechnology in medicine, namely nanomedicine, is rapidly evolving and opens new prospects for brain imaging and drug delivery into the brain. Nanomedicine when combined with nuclear medicine can offer new, promising and innovative means towards this direction through radiolabeled nanoparticles.

Nanoparticles radiolabeled with β-, γ- or β+-emitters can cross the BBB and play major role in CNS imaging and/or drug delivery.

Keywords: Blood-brain-barrier, drug delivery, nanomedicine, nanoparticles, positron emission tomography (PET), radiopharmaceuticals, single photon emission computed tomography (SPECT).

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 14 December, 2015
Page: [4257 - 4270]
Pages: 14
DOI: 10.2174/0929867322666151029105302
Price: $65

Article Metrics

PDF: 36